East Rutherford, NJ – October 17, 2024 – Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that their stability storage business, Q1 Scientific, has opened a new cGMP facility in Durham, North Carolina, expanding its capacity for environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries in North America.

Strategically located in the Research Triangle Park region, the new state-of-the-art temperature-controlled and monitored storage facility provides 7 ICH stability chambers, covering a range of conditions including 2-8°C, 25°C/60%RH, 30°C/65%RH, 30°C/75%RH, and 40°C/75%RH, as well as both -20°C and ultra-low (-70°C/-80°C) storage conditions. The facility’s Research Triangle Park (RTP) location in North Carolina will provide same day and next day delivery across the United States.

Tom Loewald, Cambrex CEO, stated, “After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific.”

Q1 Scientific’s expansion complements its existing facilities in Waterford, Ireland and Liège, Belgium, and is co-located within Cambrex’s existing analytical services site in Durham.

Stephen Delaney, Managing Director of Q1 Scientific, added, “With the capabilities and expertise co-located in Durham, we can now deliver services beyond stability storage, such as stability testing and other analytical services for clinical and commercial products.”

Cambrex continues to expand its capabilities and capacity across its North American and European network to meet the growing demand for outsourced drug development and manufacturing services.